Shantell Laketa Heiber

Array ( [id] => 6769523 [patent_doc_number] => 20030215463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Means of inducing durable immune responses' [patent_app_type] => new [patent_app_number] => 10/395822 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20211 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215463.pdf [firstpage_image] =>[orig_patent_app_number] => 10395822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1088878 [patent_doc_number] => 06828113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'IgM antibodies to the 70 kDa heat shock protein as a marker for cytomegalovirus infection' [patent_app_type] => B2 [patent_app_number] => 10/394491 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5812 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828113.pdf [firstpage_image] =>[orig_patent_app_number] => 10394491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429807 [patent_doc_number] => 20040001850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Novel human cytomegalovirus DNA sequences' [patent_app_type] => new [patent_app_number] => 10/394848 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 15048 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001850.pdf [firstpage_image] =>[orig_patent_app_number] => 10394848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631437 [patent_doc_number] => 20060147906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Anti-hpv-16 e7 antibodies and their use' [patent_app_type] => utility [patent_app_number] => 10/508766 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18148 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147906.pdf [firstpage_image] =>[orig_patent_app_number] => 10508766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069049 [patent_doc_number] => 20050244432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/508242 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5028 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244432.pdf [firstpage_image] =>[orig_patent_app_number] => 10508242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911874 [patent_doc_number] => 20050175632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Viral antigens' [patent_app_type] => utility [patent_app_number] => 10/508222 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5835 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175632.pdf [firstpage_image] =>[orig_patent_app_number] => 10508222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467939 [patent_doc_number] => 20040120944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Antibody-containing blend obtained from eggs' [patent_app_type] => new [patent_app_number] => 10/384812 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5057 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120944.pdf [firstpage_image] =>[orig_patent_app_number] => 10384812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821712 [patent_doc_number] => 20030219873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => new [patent_app_number] => 10/371846 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8583 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219873.pdf [firstpage_image] =>[orig_patent_app_number] => 10371846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905159 [patent_doc_number] => 20050100554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Complexes and methods of using same' [patent_app_type] => utility [patent_app_number] => 10/367057 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25240 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100554.pdf [firstpage_image] =>[orig_patent_app_number] => 10367057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710519 [patent_doc_number] => 20030170268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Human papilloma virus treatment' [patent_app_type] => new [patent_app_number] => 10/365908 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10418 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170268.pdf [firstpage_image] =>[orig_patent_app_number] => 10365908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851323 [patent_doc_number] => 20030143526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Recombinanr hhv8 dna' [patent_app_type] => new [patent_app_number] => 10/220640 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4468 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143526.pdf [firstpage_image] =>[orig_patent_app_number] => 10220640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821565 [patent_doc_number] => 20030219726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Detection of abnormalities leading to cervical malignancy' [patent_app_type] => new [patent_app_number] => 10/350719 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20078 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219726.pdf [firstpage_image] =>[orig_patent_app_number] => 10350719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 933884 [patent_doc_number] => 06977079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'Avian pneumovirus vaccine' [patent_app_type] => utility [patent_app_number] => 10/346542 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6768 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977079.pdf [firstpage_image] =>[orig_patent_app_number] => 10346542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071782 [patent_doc_number] => 06841364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-11 [patent_title] => 'Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof' [patent_app_type] => utility [patent_app_number] => 10/346004 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9091 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841364.pdf [firstpage_image] =>[orig_patent_app_number] => 10346004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014527 [patent_doc_number] => 06893869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule' [patent_app_type] => utility [patent_app_number] => 10/341431 [patent_app_country] => US [patent_app_date] => 2003-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 16687 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/893/06893869.pdf [firstpage_image] =>[orig_patent_app_number] => 10341431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1199352 [patent_doc_number] => 06723317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Antibodies specific for seroreactive regions on HPV 16 protein E1' [patent_app_type] => B2 [patent_app_number] => 10/340783 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6609 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723317.pdf [firstpage_image] =>[orig_patent_app_number] => 10340783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993523 [patent_doc_number] => 06916622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Regions of papilloma virus E1 helicase involved in E1 oligomerization' [patent_app_type] => utility [patent_app_number] => 10/339268 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17205 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916622.pdf [firstpage_image] =>[orig_patent_app_number] => 10339268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740323 [patent_doc_number] => 20030157692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof' [patent_app_type] => new [patent_app_number] => 10/319532 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7513 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157692.pdf [firstpage_image] =>[orig_patent_app_number] => 10319532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856393 [patent_doc_number] => 07374767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors' [patent_app_type] => utility [patent_app_number] => 10/499458 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4250 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/374/07374767.pdf [firstpage_image] =>[orig_patent_app_number] => 10499458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682745 [patent_doc_number] => 20030118609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Compositions, preparations and uses of human papillomavirus L1 protein' [patent_app_type] => new [patent_app_number] => 10/301260 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4500 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118609.pdf [firstpage_image] =>[orig_patent_app_number] => 10301260 [rel_patent_id] =>[rel_patent_doc_number] =>)